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We would like to thank Rebecca Dimond and Atina Krajewska,1 Sandra Gonza´lez-
Santos,2 and Tetsuya Ishii3 for their thoughtful comments on our article.4 Here we will
reply to their commentswhile at the same timeweprovide further clarificatory notes re-
garding what transpired inMexico, in relation to the use of mitochondrial replacement
techniques (MRTs).
WHAT’S IN A NAME?
MRTs are new reproductive techniques where the nuclear DNA of an egg, or zygote,
that was housed in a cell with deleteriously mutated mitochondria is transferred to
a donated enucleated egg, or zygote, that possesses healthy mitochondria.5 The term
MRTs has been used to refer to two techniques: pronuclear transfer andmaternal spin-
dle transfer. In her commentary, from a science and technology studies perspective,
Gonza´lez-Santos criticizes the use of this term. She argues that using it ‘helps silence
each technique’s particular history, intended purpose, and technological and biological
implications; it inaccurately suggests that what is being replaced is the mitochondria,
1 Rebecca Dimond & Atina Krajewska, Comment on MRT and the birth of the ‘first,’ J. L. BIOSCI. 1–9 (2017).
2 SandraGonza´lez-Santos,Shifting the Focus on theLegality of the FirstMaternal SpindleTransferCase, J. L. BIOSCI.
1–5 (2017).
3 Tetsuya Ishii,Mitochondrial Replacement Techniques and Mexico’s Rule of Law: On the Legality of the First Ma-
ternal Spindle Transfer Case, J. L. BIOSCI. 384–390 (2017).
4 Ce´sar Palacios-Gonza´lez &Mar´ıa de Jesu´s Medina-Arellano,Mitochondrial Replacement Techniques and Mex-
ico’s Rule of Law: On the Legality of the First Maternal Spindle Transfer Case, 4 J. L. BIOSCI. 50–69 (2017).
5 For a detailed account of what are MRTs, see Id.
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and it fails to highlight that themitochondria are not the only thing involved’.6 She also
criticizes the alternative term ‘nuclear transfer’ since it, just asMRTs, also blurs the role
played by the oocyte provider.7 We agree withGonza´lez-Santos in that the termMRTs
is problematic—one of us has elaborated on this topic8—and we find it puzzling that
in her comment she did not propose an alternative way of naming these techniques,
independently and jointly, that addresses the issues that she so clearly pointed out.
DEVELOPMENTS IN MRTs
Three relevant things have happened since in September9 last year the news broke
about the first baby born after anMRT procedure:
i. John Zhang and his team published a paper about their experiment, and a criti-
cal editorial was published alongside it.10
ii. MRTs have been used in order to aid an infertile couple, whose infertility
was not related to a mitochondrial DNA disease, to have a genetically related
child.11
iii. Zhanghas set up a company toprovide assisted reproductive services thatmight
includeMRTs.12
Some of the details provided in the editorial that accompanied Zhang’s paper are
important for our discussion of the legality of the first maternal spindle transfer case,
specifically the details concerning where theMRT and embryo transfer took place:
6 Gonza´lez-Santos, supra note 2 at 5.
7 For similar arguments, see Stuart A. Newman, Deceptive Labeling of a Radical Embryo Construc-
tion Technique, THE HUFFINGTON POST (2014), http://www.huffingtonpost.com/stuart-a-newman/
deceptive-labeling-of-a-r b 6213320.html (accessed July 20, 2016); Franc¸oise Baylis, The Ethics of Creating
Children WithThree Genetic Parents, 26 REPROD. BIOMED. ONLINE 531–534 (2013); Franc¸oise Baylis,Human
Nuclear Genome Transfer (So-CalledMitochondrial Replacement): Clearing the Underbrush, 31 BIOETHICS 7–19
(2017); Vardit Ravitsky, Stanislav Birko & Raphaelle Dupras-Leduc,The ‘Three-Parent Baby’: A Case Study of
HowLanguage Frames the EthicalDebate Regarding anEmergingTechnology, 15AM. J.BIOETHICS 57–60 (2015);
Stuart A. Newman, FDA Asked to Approve Creation of Genetically Modified Children, THE HUFFINGTON POST
(2014), http://www.huffingtonpost.com/stuart-a-newman/fda-asked-to-approve-crea b 4809876.html
(accessed Sept. 18, 2016); Ainsley J. Newson & AnthonyWrigley, Is Mitochondrial Donation Germ-Line Gene
Therapy? Classifications and Ethical Implications, 31 BIOETHICS 55–67 (2017).
8 Ce´sar Palacios-Gonza´lez, Mitochondrial Replacement Techniques: Egg Donation, Genealogy and Eugenics, 34
MONASH BIOETHICS REV. 37–51, 40 (2016).
9 Jessica Hamzelou, Exclusive: World’s First Baby Born With New ‘3 Parent’ Technique, NEW SCIENTIST (2016),
https://www.newscientist.com/article/2107219-exclusive-worlds-first-baby-born-with-new-3-parent-
technique/ (accessed Oct 3, 2016).
10 John Zhang et al., Live Birth Derived FromOocyte Spindle Transfer to PreventMitochondrial Disease, 34 REPROD.
BIOMED. ONLINE 361–368 (2017); Mina Alikani et al., First Birth Following Spindle Transfer for Mitochondrial
ReplacementTherapy: Hope and Trepidation, 34 REPROD. BIOMED. ONLINE 333–336 (2017).
11 Peter Dockrill,World-First in Ukraine as ‘Three-Parent’ Baby Born to an Infertile Couple, SCIENCEALERT (2017),
http://www.sciencealert.com/world-first-in-ukraine-as-three-parent-baby-born-to-an-infertile-couple (ac-
cessed July 5, 2017).
12 Emiliy Mullin,The Fertility Doctor Trying to Commercialize Three-Parent Babies, MIT TECHNOLOGY REVIEW,
2017, https://www.technologyreview.com/s/608033/the-fertility-doctor-trying-to-commercialize-three-
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[T]he ovarian stimulation cycles and oocyte manipulations were carried out at a private
fertility clinic inNewYork, the vitrified embryowas then shipped toMexico to bewarmed
and transferred to the patient at an affiliate clinic in Guadalajara.13
When we examined the legality of this case, we did so according to the information
that at that timewas available to us.14,15 At thatmoment everything pointed toward the
fact that the MRT procedure and the embryo transfer took place in Mexico, and thus
we concluded that Zhang’s team had violated federal regulations on health research,
specificallyArticle 56 of theRegulations of theGeneralHealthLawonHealthResearch
(henceforth: the Regulations):
Researchon assisted fertilizationwill only be admissiblewhen it is applied to solve sterility
problems that cannot be solved otherwise, respecting the couple’s moral, cultural, and
social points of view, even if these differ from those of the researcher.16
Now we know that the MRT procedure took place in the USA and it seems that this
modus operandi will not change in the foreseeable future, since Zhang was recently
quoted stating this.17,18 After these revelations,wemust now rectify our original position,
whichdeparted froma false premise, and assert thatZhang’s teamdidnot violateArticle
56 of theRegulations.They did not do so given that theMRTprocedure happened out-
side of Mexico. Given this, in what follows we will take the comments by Dimond and
Krajewska, and Ishii and interpret them as talking about the overall legality ofMRTs in
Mexico.
It is important to emphasize that our general assessment of the legality of carrying
out MRTs in Mexico still stands. This assessment is relevant at the present time, given
that New Hope Fertility Center Mexico’s Internal Review Board (IRB) not only ap-
proved the transfer of the reconstituted embryo, but also ‘approved a general protocol
that included spindle transfer, oocyte reconstitution, intra-cytoplasmic sperm injection
(ICSI), and preimpantation (sic) genetic screening (PGS)’.19 This means that the IRB
gave Zhang and his team the ‘ethical green light’ to move ahead with MRTs in their
Mexican clinics.
WHO CAN ACCESS MRTs IN MEXICO AT THE MOMENT?
In our paper we provided an answer to the question: How canMRT research be legally
carried out inMexico?We asserted thatMRT research would be legal, in principle, if it
13 Alikani et al., supra note 10, at 333.
14 Whereas Zhang’s paper and the accompanying editorial were published onApril 2017, our paper was accepted
for final publication on December 2016.
15 Palacios-Gonza´lez andMedina-Arellano, supra note 4, at 51.
16 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, REGLAMENTO DE LA LEY GENERAL
DE SALUD EN MATERIA DE INVESTIGACIO´N PARA LA SALUD (1987), http://www.diputados.gob.mx/
LeyesBiblio/regley/Reg LGS MIS.pdf (accessed July 8, 2017).
17 In an unpublished paper Gonza´lez-Santos has examined how the language used by Dr Alejandro Chavez
Badiola, Medical Director and Founder of New Hope Fertility Center Mexico, during media interviews
concealed the fact that the MRT procedure happened in the USA. For example: NOTICIEROS TELEVISA,
NACIMIENTO DE BEBE´ CON ADN DE TRES PADRES EN ME´XICO - DESPIERTA CON LORET 1:10/2:00 (2016),
https://www.youtube.com/watch?v=0geikNJh9zI (accessed Aug. 15, 2017).
18 Quoted inMullin, supra note 12.
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aimed at solving sterility problems that could not be solved otherwise. In his commen-
tary on our paper, Ishii finds the above conclusion about the general legality of MRTs
in Mexico problematic. He asserts that our ‘legal interpretation paradoxically suggests
that researchonexperimental SNT[spindlenuclear transfer]will be admissible to solve
‘sterility problems’ at fertility clinics in Mexico’.20
Even though we share some of Ishii’s worries about the use of MRTs for ‘treating’
infertility that is not related to mtDNA diseases, we must accept that in terms of the
Mexican law MRT research for dealing with all types of sterility would be legal if they
followed Article 56 of the Regulations. In other words, in Mexico researchers can of-
fer MRTs to women, or couples, when such techniques are aimed at solving sterility
problems that cannot not be solved otherwise, regardless of the underlying medical
condition.
STERILITY AND THE MEXICAN LAW
The above section tells us that the concept of ‘sterility’ is of the utmost importance in
order to determine who might legally access MRTs inMexico. Ishii is right in that nei-
ther the General Health Law nor the Regulations provide a legal definition of sterility.
When we wrote our paper we realized this, and this is why we provided the definition
that appears in a clinical guideline of theMexican Social Security Institute. In this clin-
ical guideline, infertility and sterility are treated as synonyms, and are defined as: ‘the
failure to achieve clinical pregnancy after 12 months of regular unprotected sexual in-
tercourse’.21 In our paper,we interpreted this tomean the inability to produce and deliver
live offspring, and that once there is a live delivery women should no longer be regarded
as sterile. In this sense, we were following theWHO’s definition of ‘primary infertility’:
When a woman is unable to ever bear a child, either due to the inability to become preg-
nant or the inability to carry a pregnancy to a live birth she would be classified as hav-
ing primary infertility.Thuswomenwhose pregnancy spontaneouslymiscarries, orwhose
pregnancy results in a still born child, without ever having had a live birth would present
with primarily infertility.22
Ishii, on the other hand, argues that scientists working onMRTs could defend a dif-
ferent understanding of this concept. According to him ‘researchers could emphasize
that sterility is a state of difficulty in conceiving, which cannot be defined based solely
on pregnancy and delivery’.23 He cites the following textbook definition of sterility to
support his case: ‘After 18 months of unprotected sexual intercourse, the remaining
couples have a low monthly conception rate without treatment, and many may have
absolute defects preventing fertility (sterility)’.24 From both these quotes, it is reason-
able to conclude that Ishii’s understanding of this term is close to theWHO’s definition
20 Ishii, supra note 3 at 384–385.
21 INSTITUTO MEXICANO DEL SEGURO SOCIAL, DIAGNO´STICO DE LA PAREJA INFE´RTIL Y TRATAMIENTO CON
TE´CNICASDEBAJACOMPLEJIDAD(2012), http://www.imss.gob.mx/sites/all/statics/guiasclinicas/621GRR.pdf
(accessed July 8, 2017).
22 World Health Organization, WHOffiINFERTILITY DEFINITIONS AND TERMINOLOGY WHO (2017),
http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ (accessed July 8, 2017).
23 Ishii, supra note 3 at 387.
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of ‘secondary infertility’:
When a woman is unable to bear a child, either due to the inability to become pregnant
or the inability to carry a pregnancy to a live birth following either a previous pregnancy
or a previous ability to carry a pregnancy to a live birth, she would be classified as having
secondary infertility. Thus those who repeatedly spontaneously miscarry or whose preg-
nancy results in a stillbirth, or following a previous pregnancy or a previous ability to do
so, are then not unable to carry a pregnancy to a live birth would present with secondarily
infertile.25
In order to provide legal clarity about how the term ‘sterility’ should be understood,
we decided to search the online database of the ‘Federal Judicial Weekly’ for the con-
cepts ‘infertility’ and ‘sterility’; it is in this publication where the jurisprudences and
relevant cases solved out by the Mexican Supreme Court of Justice and federal circuit
courts are compiled.26 At present time, there is no jurisprudenceor relevant caseswhere
these concepts are extensively defined.However, we found three relevant cases from the
1960s (pertaining to the state of Jalisco) where federal circuit courts provided a defi-
nition of ‘sterility’.27 In all three cases, the courts were solving out disputes of divorce,
and in all three of them ‘sterility’ was simply defined, in women, as the inability to con-
ceive. Although these cases favor our interpretation of ‘sterility’ over Ishii’s one, it is
important to note that such a definition is not legally binding, but that it should be re-
garded as a relevant precedent.28 Furthermore, the ruling of the Inter-American Court
of Human Rights in the case of Artavia Murillo et al. vs. Costa Rica, that is also bind-
ing for Mexico,29 defines infertility just as the Mexican Social Security Institute does,
thus providing no further clarity on this issue.30 Given how the Mexican law is written
at the present time, and these diverging possible understandings of the term ‘sterility’,
we have to conclude that we will have to wait either (a) for the law to change and de-
fine sterility/infertility or (b) for a relevant case to be brought again to the courts where
they are required to define these terms in more detail.
A further point that Ishii puts forward is that scientists offeringMRTs, as part of re-
search protocol, could try to defend the legality of their research by appealing to Article
25 World Health Organization, supra note 22.
26 Suprema Corte de Justicia de la Nacio´n, SEMANARIO JUDICIAL DE LA FEDERACIO´N (2017),
https://sjf.scjn.gob.mx/SJFSist/paginas/tesis.aspx (accessed June 12, 2017).
27 AMPARO DIRECTO 4663/59. DA´MASO PARRA. 8 DE JUNIO DE 1961. CINCO VOTOS. PONENTE: MARIANO RAMI´REZ
VA´ZQUEZ; AMPARO DIRECTO 101/60. GABRIELA MERCEDES GALLARDO CABRERO DE AGUILERA. 14 DE OCTUBRE
DE 1960. UNANIMIDAD DE CUATRO VOTOS. PONENTE: MARIANO RAMI´REZ VA´ZQUEZ; AMPARO DIRECTO 101/60.
GALLARDO CABRERO DE AGUILERA GABRIELA MERCEDES. 14 DE OCTUBRE DE 1960. UNANIMIDAD DE CUATRO
VOTOS. LA PUBLICACIO´N NO MENCIONA EL NOMBRE DEL PONENTE.
28 Here we do not have enough space to explain why these rulings are not legally binding, for an in-depth
explanation of why this is so see, particularly in chapter 1: MARIA DE JESU´S MEDINA-ARELLANO, THE QUEST
FOR STEM CELL SCIENCE REGULATION IN MEXICO: CONTROVERSIES IN A CONTESTED SECULAR STATE, June
2012, https://www.escholar.manchester.ac.uk/api/datastream?publicationPid=uk-ac-man-scw:165929&
datastreamId=FULL-TEXT.PDF (accessed Aug. 12, 2016).
29 Palacios-Gonza´lez andMedina-Arellano, supra note 4, at footnote 16.
30 Inter-American Court of Human Rights, Case of Artavia Murillo et al. (‘In vitro fertilization’) v. Costa Rica,
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47 of the Regulations, which states:
Research in pregnant women, with therapeutic benefit related to pregnancy, shall be per-
mitted when: (. . . ) II.They are aimed at increasing the viability of the fetus, with minimal
risk to the pregnant woman.31
We contend that Ishii is mistaken regarding this point, the source of his error is that
this article does not apply to research scenarios where the woman is not already preg-
nant, as would be the case whenMRTs are first offered.32
HEALTH RESEARCH/CLINICAL PRACTICE
In their commentary to our paper, Dimond and Krajewska do two things: they elabo-
rate on the international significance of the first live birth following an MRT and they
offer an alternative interpretation of the legality ofMRTs inMexico, by focusing on the
distinction between health research/clinical practice. Here we will only focus on their
second point. Dimond and Krajewska note that if we can prove that MRTs do not fall
within the remit of health research, thenArticle 56 of theRegulationswould not apply to
them, and thusMRTs could be offered across the board. In order to do exactly this, they
start by raising the question of how is it that preimplantation genetic diagnosis (PGD)
became approved inMexico, and they assert that:
[It is not possible] to identify the precise moment, in which it became a fully accept-
able clinical procedure.This is because the clear distinction between research and clinical
practice stipulated in legal documents remains almost impossible tomaintain in practice.
This fluidity is exacerbated in the case of novel reproductive technologies, the full conse-
quences of which will not be known for years, or even generations, to come.33
The above assertion, in a more general sense, seems to point toward the fact that
there are three possible ways in which to understand the status of assisted reproduc-
tive technologies within the Mexican law: that all assisted reproductive technologies
fall within the remit of health research; that there is a point, or period, from where a
reproductive technique no longer falls within the remit of health research (this is the
interpretation that we endorsed in our paper); and that all assisted reproductive tech-
nologies can be regarded as being part of clinical practice from the outset.
Of these possible interpretations they seem to favor the first one, suggesting that all
ARTs can in a sense be regarded as part of research. Now, if we, for sake of argument,
acceptDimond andKrajewska’s interpretation, thenwhatwould actually follow, contra
their conclusion, is that in Mexico both PGD andMRTs are part of health research and
thus fall within the remit of Article 56 of the Regulations.This follows because the def-
inition of ‘health research’ provided in the Regulations is really broad, Article 3 asserts
that: ‘Health research entails carrying out actions that contribute: (. . . ) III. To the pre-
vention and control of health problems’.34 We thankDimond andKrajewska for noting
31 CA´MARA DE DIPUTADOS DEL H. CONGRESO DE LA UNIO´N, supra note 16.
32 Ce´sar Palacios-Gonza´lez,AreThere Moral Differences Between Maternal Spindle Transfer and Pronuclear Trans-
fer?, MED. HEALTH CARE PHILOS. 1–9 (2017).
33 Dimond & Krajewska, supra note 1, at 2–3.
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this alternative interpretation of the status of assisted reproductive technologies within
the Mexican law. Their interpretation further shows the urgency of legislative reform
on the regulation of assisted reproductive techniques and health research inMexico.
We want to conclude this article by stating that with the looming prospect of inter-
nationalMRT tourism ahead, we would greatly benefit from a global discussion on the
ethics and regulation of new reproductive technologies that can inform both regional
and international policy making.35
35 While this papers was under review (on August 4, 2017) the US Food and Drug Administration sent a
very strongly-worded letter to Dr. Zhang. In that letter the FDA listed -in a non all-inclusive way- the
violations to US regulations incurred by Zhang’s team, and also asked him to stopmarketingMRTs in the US.
https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/
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